Opioid ECHO

Prescribers & Dispensers Schedule

The OUD ECHO Prescriber & Dispensers is an online Tele ECHO program designed to connect primary care teams with inter-disciplinary specialist teams to spread knowledge, on how to manage, treat and provide best care practice for complex chronic health conditions with a focus on addiction, and opioid use disorder (OUD) diagnosis.

This ECHO clinic begins January 11, 2023 through December 13, 2023 and will meet every other Wednesday from 12pm to 1:30pm EST. There is no cost to join, and you can earn free continuing education credits (CME). You can register for this clinic now:

Would you like feedback and recommendations on how to treat and manage a patient’s diagnosis? De-identified case presentations from participants are key parts of an ECHO clinic. You can submit a confidential, de-identified case by using this Qualtrics survey.

Schedule: 2023 Curriculum

Date	Topic	Presentation
Jan 11, 2023	Introduction to MAT	View
Jan 25, 2023	Overview of Medicated Assisted Treatment & Data Waiver Requirements	View
Feb 8, 2023	Pharmacist Role in MAT	View
Feb 22, 2023	How OUD & MAT affects the Brain Chemistry	View
March 8, 2023	What's New in Pain and Addiction Treatment or The Novel Drug	View
March 22, 2023	Peer Recovery Indiana Pregnancy Program	View View
April 5, 2023	Legal Issues Facing Those with OUD	View
April 19, 2023	Opioid Addiction Risk in Chronic Pain Patients	View
May 3, 2023	Precipitative Withdraw and Induction	View
May 17, 2023	Overdose Awareness and Prevention	View
May 31, 2023	Understanding and Treating Hepatitis C in Patients Who Use Drugs	View
June 14, 2023	Behavioral Traits linked to Addiction - Neuro imaging - Participate in amazing futuristic study and receive compensation	View VR Flyer Participate
June 28, 2023	Psychosis/ Mania and Amphetamine Use	View
July 12, 2023	Recovery Capital in MAT	View
July 26, 2023	Drug Testing/Patient Agreements & Non-compliance	View
August 9, 2023	Education Updates for a DEA holders (new MATE Act)	View
August 23, 2023	Stigma in OUD Medications	View
September 6, 2023	Psychedelics For Treatment of Use Disorders	View
September 20, 2023	No Session
October 4, 2023	Ketamine in OUD	View
October 18, 2023	Medical Records Documentation	View
November 1, 2023	Harm Reduction	View
November 15, 2023	Xylazine origin, and effects with opioid use disorder
November 22, 2023	Holiday
November 29, 2023	Use of Subclade vs Sublingual
December 13, 2023	Removing the Stigma from Substance Use Disorder
December 27, 2023	Holiday

Past Sessions (Jan 2022 - Dec 2022)

Date	Topic	Presentation
1/5/2022	Introduction to MAT	View
1/12/2022	The Role of a Pharmacist in MAT	View
1/19/2022	Overview of Medicated Assisted Treatment & Data Waiver Requirements	View
1/26/2022	Peer Recovery	View
2/2/2022	Drug Testing/Patient Agreements/Non-compliance	View
2/9/2022	Overview of Cognitive Behavior Therapy and DBT	View
2/16/2022	Vivitrol and its Use	View
2/23/2022	SUD in LGBTQ/OUD SUD Stigma	View
3/2/2022	How OUD & MAT affects the Brain Chemistry	View
3/9/2022	Overdose Lifeline -Short Guide to Harm Reduction	View
3/16/2022	The latest Street Drugs; How to Detect; How to Treat; What are They Called	View
3/23/2022	Peer Recovery Coach	View
3/30/2022	Compliance & Monitoring Patients with OUD	View
4/6/2022	AAA Program - Update on Diagnosis, Assessment and Treatment of Alcohol Use Disorder	Part 1 Part 2
4/13/2022	Suicide risk assessment	View Flyer
4/20/2022	Addressing Women and Addiction	View
4/27/2022	Recovery Capital	View Scale
5/4/2022	Introduction to MAT	View
5/11/2022	Landlord Mitigation Reserve program / Recovery House & Oxford House	Part 1 Part 2 Part 3
5/18/2022	Chronic Pain and OUD	View
5/25/2022	Pharmacist Role in OUD	View
6/1/2022	Pain management and Buprenorphine	View
6/8/2022	Legal Issues in OUD and Resources for Pregnant Women with OUD In and Out of Incarceration	Part 1 Part 2
6/15/2022	Drug Testing/Patient Agreements/Non-compliance & Landlord Mitigation	Part 1 Part 2
6/22/2022	Addiction Therapy in Primary Care when patients won’t receive Counseling or MAT	View
6/29/2022	Harm Reduction Strategies	Part 1 Part 2
7/6/2022	Weaning MAT	View
7/13/2022	Overview of Cannabinoids	View
7/20/2022	Use of Subclade vs Sublingual	View
7/27/2022	Peer Recovery Coaching	View
8/3/2022	Psychosis and Amphetamine Use	View
8/10/2022	OUD Affect on Brain Chemistry	View
8/17/2022	Harm Reduction Strategies	View
8/24/2022	Tobacco Use Disorder	View
8/31/2022	How to Prepare for a DEA Audit	View
9/7/2022	Stigma & Racial Disparities in Treatment of OUD	View
9/14/2022	MAT in the ED, Meth and More	View
9/21/2022	Common Drug Trends, Treatment in ED Settings Tyler Stepsis	View
9/28/2022	988 Suicide & Crisis Lifeline	View
10/5/2022	[No session this week]
10/12/2022	Tracking and monitoring of controlled substance handling within the healthcare setting	View
10/19/2022	Office-Based Management of Opioid USE Disorder (OUD): Evaluation of New Patients for Opioid Agonist Treatment (OAT)	View
10/26/2022	The Use (Misuse) of Gabapentin with SUD/OUD	View
11/2/2022	Psychosis and Amphetamine Use	View
11/9/2022	Legal Issues in OUD	View
11/16/2022	Strategies to Wean from MAT How long and discontinuation strategies for buprenorphine	View
11/23/2022	[No session this week]
11/30/2022	Acute Pain in OUD	View
12/7/2022	ADHD Bipolar Disorder Methamphetamine Use Disorder	View
12/14/2022	Crisis Intervention	View
12/21/2022	[No session this week]
12/28/2022	[No session this week]

Past Sessions (Sep 2021 - Dec 2021)

Date	Topic	Presentation
9/1/2021	CBD & the Endocannabinoid System	View
9/8/2021	Tobacco Use Disorder	View
9/15/2021	Engaging Adolescents in Treatment: Motivational Interviewing	View
9/22/2021	Recovery Assist	View
9/29/2021	Harm Reduction	View
10/6/2021	MAT and Buprenorphine induction	View
10/13/2021	Neurobiology	View
10/20/2021	Pharmacist Role in MAT	View
10/27/2021	Pharmacology	View
11/3/2021	Drug Trends	View
11/10/2021	Methamphetamine withdrawal and psychosis	View
11/17/2021	Harm Reduction	View
11/24/2021	[No session this week]
12/1/2021	Hidden drugs of abuse	View
12/8/2021	Novel Drugs	View
12/15/2021	TBD
12/22/2021	[No session this week]
12/29/2021	[No session this week]

Past Sessions (Sept 2020 - Aug 2021)

Date	Topic	Presentation
9/30/2020	Medications used for Alcohol Use Disorder	View
10/7/2020	Legal Issues Related to OUD	View
10/14/2020	[NO SESSION]
10/21/2020	How to treat OUD in patients with Traumatic Brain Injuries	View
10/28/2020	Best Practices for SUD by Managed Care Companies	View
11/4/2020	Treatments for Tobacco Use Disorder	View
11/11/2020	Harm Reduction Strategies	View
11/18/2020	Behavioral Health Interventions	View
11/25/2020	[NO SESSION]
12/2/2020	Peer Recovery Coaching	View
12/9/2020	Addressing Pain Management in OUD Patients	View
12/16/2020	OUD & Suicide Risks	View
1/6/2021	Indiana Recovery Housing Resources	N/A
1/13/2021	Adverse Childhood Experiences	Position Statement
1/20/2021	Pharmacists Role in the Treatment of OUD	View
1/27/2021	Connection of Human Trafficking to SUD	Position Statement
2/3/2021	Treating OUD in Primary Care Offices	View
2/10/2021	Addressing Psychiatric Concerns in Primary Care Offices	View
2/17/2021	General Overview of Stimulant Use Disorder and Affects on the Brain	View
2/24/2021	Pharmacotherapy of Treating Stimulant Use Disorder and Stimulant Withdrawal	View
3/3/2021	Treatment of Chronic Psychosis from Stimulants & Behavioral Interventions	View
3/10/2021	Acute and Chronic Complications of Methamphetamine Use	View
3/17/2021	Prescription Stimulant Abuse	[Not Available]
3/24/2021	Contingency Management for the Treatment of Methamphetamine Use Disorder	View
3/31/2021	Withdrawal and Cognitive Impairment of Opioid Use Disorder	View
4/7/2021	[No Session]
4/14/2021	Legal Issues Related to OUD	View
4/21/2021	Motivational Interviewing	View
4/28/2021	Harm Reduction Strategies	View
5/5/2021	Psychiatric Co-morbidities	View
5/12/2021	Stigma Reduction	View
5/19/2021	Overview of Medications used for the Treatment of OUD	View
5/26/2021	Non-pharmacological Treatment of OUD	View
6/2/2021	Long-acting Injectable Buprenorphine	View
6/9/2021	Induction of Medications to Treat OUD	View
6/16/2021	Buprenorphine Weaning and Tapering	View
6/23/2021	Compliance & Monitoring Patients with OUD	View
6/30/2021	Resiliency and Provider Self Care	View
7/7/2021	[No session this week]
7/14/2021	Peer Support and Regional Recovery Hubs	View
7/21/2021	Behavioral Health Interventions	View
7/28/2021	Overview of Sythetic Cannabinoids	View
8/4/2021	Pharmacists Role in Treatment OUD	View
8/11/2021	Treatment in ED Settings	View
8/18/2021	Treating Pain in Patients with OUD	View
8/25/2021	Indiana Resources	View

Past Sessions (Feb 2020 - Sept 2020)

Date	Topic	Presentation
February 12	Overview of MAT & Data Waiver	View
February 19	Assessment of OUD	View
February 26	Induction of MAT	View
March 4	How OUD & MAT affect the brain	View
March 11	Drug Testing/Patient agreement/non-compliance	View
March 18	How to Prepare for DEA Audit	View
March 25	SUD and COVID-19	View
April 1	Harm Reduction Strategies	View
April 8	Telehealth	View
April 15	Pharmacists Role in OUD	View
April 22	COVID-19 MAT Prescribing Guidance	View
April 29	ASAM COVID Resources	View
May 6	Methamphetamines	View
May 13	Peer Recovery Network - COVID Resources	View
May 20	Compassionate Weaning of Opioids for Pain	View
May 27	Sleep Hygiene	View
June 3	Common Drug Trends	View
June 10	Anxiety and SUD	View
June 17	Motivational Interviewing 2.0	View
June 24	When and How to Taper Medications for OUD	View
July 1	[No session]
July 8	NAMI Mental Health Resources	View
July 15	Overview of Drug and Specialty Courts	View
July 22	Overview and Induction of Medications used to treat OUD	View
July 29	Long acting injectable Buprenorphine	View
August 5	Treatment of OUD in those with Traumatic Brain Injuries	View
August 12	Integrated Care Approach to treating OUD	View
August 19	Screening for Traumatic Brain Injuries	View
August 26	Compliance and Monitoring Patients on Medicated Assisted Treatment	View
September 2	Overdose Awareness and Prevention	View
September 9	A Case of Family Addiction - Effects on the Child	View
September 16	INSPECT Updates – Indiana’s Prescription Monitoring Program	N/A
September 23	Functional Analysis and other Behavioral Health Screening Tools	View

Past Sessions (Sept 2019 - Feb 2020)

Date	Topic	Presentation
September 25	Overview of MAT & Data Waiver	View
October 2	Assessment of OUD	View
October 9	Induction of MAT	View
October 16	[No clinic scheduled this week]
October 23	Methampetamines	View
October 30	[No clinic scheduled this week]
November 6	Drug Testing/Patient agreement/non-compliance	View
November 13	HIV & Hep C Testing and Screening	View
November 20	Treatment in the Emergency Dept Setting	View
December 4	SBIRT - Screening, Brief Intervention, Referral to Treatment	View
December 11	Indiana Resources	View
December 18	Indiana Rural Health Association Opioid Consortium	View
January 8	CBD & the Endocannabinoid System	View
January 15	Cognitive Behavioral Therapy	View
January 22	Recovery Works	View
January 29	Self Care and Compassion Fatigue	View
February 5	OUD & Suicide	View

Past Sessions (May 2019 - Sept 2019)

Date	Topic	Presentation
May 29	Overview of Medication-Assisted Treatment & Data Waiver	Part 1 Part 2
June 5	Assessing and Diagnosing OUD	View
June 12	Induction to MAT	View
June 19	Drug Testing/Patient Agreements/Non-Compliance	View
June 26	Neurobiology of OUD & MAT	View
July 10	Stigma Reduction	View
July 17	Legal Issued Related to OUD Patients	View
July 24	Peer Recovery Support Services	View
August 7	Harm Reduction Strategies	View
August 14	Tobacco Cessation	View
August 21	OUD in Pregnancy	View
August 28	Addressing Chronic Pain in Patients with OUD	View
September 4	Behavioral Interventions	View
September 11	Co-Occurring Mental Health Conditions	View
September 18	American Society of Addiction Medicine (ASAM) Guidelines	View